The Buffalo News reports that Garwood Medical Devices, a startup company that licenses technology developing in the lab of biomedical engineer Mark Ehrensberger, is ready to begin swine studies for BioPrax, a minimally-invasive device that uses low-voltage electricity to treat infections and kill bacteria on the surface of joint replacements.

An article in the Buffalo News reporting that Garwood Medical Devices has received a $500,000 investment from the Western New York Impact Investment Fund notes that the company uses patented electrical stimulation technology that was developed in the Department of Biomedical Engineering.

WBFO-FM reported on Buffalo startup Garwood Medical Devices, which is working with UB’s Buffalo Institute for Genomics and Data Analytics and biomedical researchers to bring to market a medical devices which aims to reduce joint replacement infections through electrical stimulation technology.